Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 377

1.

Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.

Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS.

Arch Gen Psychiatry. 1997 Apr;54(4):364-74.

PMID:
9107153
2.

Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.

Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC.

Arch Gen Psychiatry. 2004 Aug;61(8):765-73.

PMID:
15289275
3.

Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.

Ho AP, Gillin JC, Buchsbaum MS, Wu JC, Abel L, Bunney WE Jr.

Arch Gen Psychiatry. 1996 Jul;53(7):645-52.

PMID:
8660131
4.

Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.

Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O, Herscovitch P, Goldman D, Drevets WC, Charney DS.

Arch Gen Psychiatry. 2006 Sep;63(9):978-86.

PMID:
16953000
5.

Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR Jr.

Arch Gen Psychiatry. 2001 Jul;58(7):631-40.

PMID:
11448368
6.

Neuroanatomic correlates of psychopathologic components of major depressive disorder.

Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ.

Arch Gen Psychiatry. 2005 Apr;62(4):397-408.

PMID:
15809407
7.

Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion.

Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ.

Br J Psychiatry. 1999 Jun;174:525-9.

PMID:
10616631
8.

Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression.

Rosa-Neto P, Diksic M, Okazawa H, Leyton M, Ghadirian N, Mzengeza S, Nakai A, Debonnel G, Blier P, Benkelfat C.

Arch Gen Psychiatry. 2004 Jun;61(6):556-63.

PMID:
15184235
9.

Comparison of regional brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography.

Hagman JO, Buchsbaum MS, Wu JC, Rao SJ, Reynolds CA, Blinder BJ.

J Affect Disord. 1990 Jul;19(3):153-62.

PMID:
2145335
10.

Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.

Bremner JD, Vythilingam M, Ng CK, Vermetten E, Nazeer A, Oren DA, Berman RM, Charney DS.

JAMA. 2003 Jun 18;289(23):3125-34.

11.

Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression.

Wu JC, Gillin JC, Buchsbaum MS, Schachat C, Darnall LA, Keator DB, Fallon JH, Bunney WE.

J Affect Disord. 2008 Apr;107(1-3):181-6. Epub 2007 Nov 26.

PMID:
18031825
12.

Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.

Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ.

Arch Gen Psychiatry. 2003 Jan;60(1):14-22.

PMID:
12511168
13.

Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.

Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, Roiser JP, Neumeister A, Meyers N, Charney DS, Drevets WC.

Arch Gen Psychiatry. 2008 May;65(5):521-31. doi: 10.1001/archpsyc.65.5.521.

14.

Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment.

Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM, Cowen PJ.

Arch Gen Psychiatry. 2000 Feb;57(2):174-80.

PMID:
10665620
15.

Positron emission tomography study of the effects of tryptophan depletion on brain serotonin(2) receptors in subjects recently remitted from major depression.

Yatham LN, Liddle PF, Sossi V, Erez J, Vafai N, Lam RW, Blinder S.

Arch Gen Psychiatry. 2012 Jun;69(6):601-9. doi: 10.1001/archgenpsychiatry.2011.1493.

PMID:
22664549
16.

Effect of sertraline on regional metabolic rate in patients with affective disorder.

Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, Reynolds C.

Biol Psychiatry. 1997 Jan 1;41(1):15-22.

PMID:
8988791
17.

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR.

Arch Gen Psychiatry. 1990 May;47(5):411-8.

PMID:
2184795
18.

Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder.

Bremner JD, Innis RB, Ng CK, Staib LH, Salomon RM, Bronen RA, Duncan J, Southwick SM, Krystal JH, Rich D, Zubal G, Dey H, Soufer R, Charney DS.

Arch Gen Psychiatry. 1997 Mar;54(3):246-54.

PMID:
9075465
19.

Prefrontal-subcortical and limbic circuit mediation of major depressive disorder.

Brody AL, Barsom MW, Bota RG, Saxena S.

Semin Clin Neuropsychiatry. 2001 Apr;6(2):102-12. Review.

PMID:
11296310
20.

Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors.

Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH.

Arch Gen Psychiatry. 1994 Apr;51(4):309-17.

PMID:
8161291
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk